Latest Regulatory News

G11 Resources has identified a promising new copper and gold drill target at Sedgwick Bluff, Tasmania, adjacent to the historic Mt Lyell mine. The discovery, based on advanced geophysical modelling, sets the stage for imminent drilling pending environmental and regulatory approvals.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Mount Hope Mining Limited launches a $1.25 million Share Purchase Plan at $0.20 per share, matching a recent placement, to fund drilling and land acquisitions at its Mount Hope Project.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Bank Limited reported a robust half-year profit of AUD 3.67 billion, up 61% from the prior period, driven by strategic asset sales and strong loan growth. The bank’s capital position remains solid amid ongoing investments in technology and risk management.

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

Macquarie Group reported a solid half-year profit increase despite a sequential dip, boosted by strong asset management and capital markets performance. The group also extended its share buyback and declared a steady interim dividend.

Macquarie Group Limited reported a 3% increase in profit for the half year ended 30 September 2025, driven by strong performances in asset management and capital advisory, while declaring a 35% franked interim dividend of $2.80 per share.

Finexia Financial Group has formally ended preliminary discussions with Salter Brothers regarding a potential reverse listing and is seeking immediate reinstatement of its ASX securities.

VGI Partners Global Investments Limited has announced an on-market buy-back of its ordinary shares, set to begin in late November 2025 and run for a full year. The buy-back offers a flexible approach without fixed volume limits or a set price, signaling a strategic capital management move.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.